Icl Group Ltd. · TASE:ICL
Icl — Investor Day (September 2020)
16 slides from Icl's investor day presentation, Sep 23, 2020
Slide 1: Leadership, Innovation, Growth
Leadership Innovation Growth Anat Tal President, Industrial Products Division September 23, 2020
Slide 2: Important Legal Notes
IMPORTANT LEGAL NOTES Disclaimer and Safe Harbor for Forward-Looking Statements The information contained herein in this presentation or delivered or to be delivered to you during our presentation does not constitute an ofer, expressed or implied, or a recommendation to do any transaction in ICL Gro
Slide 3: ICL IP at a Glance
ICL IP AT A GLANCE Leadership, Innovation & Growth 2019 11 ~1,650 3 R&D $1,318M Sales, Manufacturing Employees Centers $405M (31%) Sites WW EBITDA 3
Slide 4: Global Leader in Bromine
GLOBAL LEADER IN BROMINE Leadership, Innovation & Growth Highest Concentration of Bromine = Lowest Cost Concentration Production & Capacities g/liter 10.0 – 12.0 China Relative Production Cost & Japan 4.5 – 5.5 Dead Sea Arkansas India 2.5 – 4.5 U.S ICL Jordan 0.5 – 0.9 0.06 – 0.11 0.1 – 0.2 SEA WATE
Slide 5: Chinese Bromine Market
Chinese Bromine Market Lower Production Lower Quality Higher Cost 2010 Natural Depletion of Bromine Resources in 2019 China, Lower Quality 2025 GOAL Stricter Environmental Regulations Lower Land Availability for Bromine Production 5 Source: ICL estimates, MarketsandMarkets
Slide 6: ICL IP Market Leadership
ICL IP MARKET LEADERSHIP Leadership, Innovation & Growth No.1 Bromine No.1 Bromine capacity compounds plant No.1 Bromine and No.1 Bromine Phosphorus Flame Iso-tank feet retardants No.1 Magnesia for No.1 Self- Nutraceutical extinguishing market Hydraulic fuids No.1 Brominated No.1 Clear biocides Brin
Slide 7: ICL IP Growth Strategy
ICL IP Growth Strategy A WORLD LEADER AND BEYOND Value From Spot to From Bromine to Grow the Portfolio- over Long Term Compounds Leveraging New Volume Agreements AI Platform 7
Slide 8: ICL IP Growth Strategy: From Spot to Long Term Agreements
ICL IP Growth Strategy From Spot to Long 2016 2019 2025 Term Agreements 43% 52% Total Bromine 30% 2% 21% Business sales 29% 28% 48% Long-term Agreements - Asia 70% 57% 22% 23% Long-term Agreements - RoW Spot sales TOTAL: 730 900 ** 1,050 $ millions * Out of the Bromine business 8 ** Targeted
Slide 9: ICL IP Growth Strategy: From Bromine to Brominated Compounds
ICL IP Growth Strategy IN PROCESS IN PROCESS IN PROCESS From Bromine to Brominated Compounds * TBBA - Isotank Fleet * TBBA ** FR-1025 Other FR for PCBs Expansion Expansion Expansion Compounds ** FR-1025 - FR for +10% UP TO UP TO Expansions connectors, EV, Automotive +25KMT +50% *UP TO $+110M PER ANN
Slide 10: Results - Grow the Core Business
RESULTS - GROW THE CORE BUSINESS RECORD EBITDA IN 2019 1,193 1,296 1,318 1,120 31% 28% 405 26% 363 26% 308 286 2016 2017 2018 2019 EBITDA SALES % EBITDA MARGIN $ million 10
Slide 11: Grow the Portfolio
GROW THE PORTFOLIO DEVELOPED A BREAKTHROUGH INNOVATIVE ARTIFICIAL INTELLIGENCE PLATFORM WHICH IDENTIFIES NEW BROMINE APPLICATIONS yi 2019-2020: Collaborating with cutting- 2 § edge Israeli Artificial Intelligence start-ups ; (Al) o to develop unique and proprietary software which has identified new
Slide 12: New Applications Focus
New applications focus e Mobility Recycling Clean Energy 12
Slide 13: ICL-IP's Target
ICL-IP’s TARGET THROUGH CONTINUED STRATEGIC EXECUTION AND NEW APPLICATIONS FOR BROMINE EBITDA TARGET FOR 2025 13 TARGETED ANNUAL GROWTH AS OF 2025
Slide 14: Thank You!
THANK YOU!
Slide 15: Reconciliation Tables
Reconciliation Tables Industrial Products 2016 2017 2018 2019 Phosphate Specialties 2017 2018 2019 Food Specialties 2019 Sales 1,120 1,193 1,296 1,318 Sales 1,126 1,197 1,111 Sales 571 Operating income 227 247 300 338 Operating income 68 117 102 Sales to externals 560 Depreciation & Amortization 59
Slide 16: Non-GAAP Financial Measures
Non-GAAP Financial Measures We disclose in presentations non-IFRS financial measures titled adjusted EBITDA, segment EBITDA, segment EBITDA margin and free cash flow. Our management uses such non- GAAP measures to facilitate operating performance comparisons from period to period and present free ca